Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia

被引：0
|
作者：
Clara Pérez-Rambla
Leonor Puchades-Carrasco
María García-Flores
José Rubio-Briones
José Antonio López-Guerrero
Antonio Pineda-Lucena
机构：
[1] Centro de Investigación Príncipe Felipe,Structural Biochemistry Laboratory
[2] Fundación Instituto Valenciano de Oncología,Laboratory of Molecular Biology
[3] Fundación Instituto Valenciano de Oncología,Department of Urology
[4] Instituto de Investigación Sanitaria La Fe,Drug Discovery Unit
来源：
Metabolomics | 2017年 / 13卷
关键词：
Biomarkers; Metabolomics; Prostate cancer; Benign prostatic hyperplasia; Nuclear magnetic resonance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The impact of benign prostatic hyperplasia on bladder volume in radiotherapy of prostate cancer
    Jang, H.
    Baek, J. G.
    Kwon, S. Y.
    Lee, K. S.
    Oh, Y. T.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2019, 17 (03): : 401 - 406
  • [32] Occupational physical activity in relation with prostate cancer and benign prostatic hyperplasia
    Lagiou, Areti
    Samoli, Evi
    Georgila, Christina
    Minaki, Ploumi
    Barbouni, Anastasia
    Tzonou, Anastasia
    Trichopoulos, Dimitrios
    Lagiou, Pagona
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2008, 17 (04) : 336 - 339
  • [33] SERUM PROSTATE-SPECIFIC ANTIGEN DISCRIMINATES WEAKLY BETWEEN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND PATIENTS WITH ORGAN-CONFINED PROSTATE-CANCER
    SERSHON, PD
    BARRY, MJ
    OESTERLING, JE
    EUROPEAN UROLOGY, 1994, 25 (04) : 281 - 287
  • [34] Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
    Hung, S-C
    Lai, S-W
    Tsai, P-Y
    Chen, P-C
    Wu, H-C
    Lin, W-H
    Sung, F-C
    BRITISH JOURNAL OF CANCER, 2013, 108 (09) : 1778 - 1783
  • [35] Statin's role on protection from the benign prostatic hyperplasia and prostate cancer
    Hasirci, Eray
    Oguzulgen, Ibrahim
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2012, 11 (04): : 270 - 274
  • [36] Decoding Benign Prostatic Hyperplasia: Insights from Multi-Fluid Metabolomic Analysis
    Xu, Xiaoyu
    Tan, Haisong
    Zhang, Wei
    Liu, Wanshan
    Chen, Yanbo
    Zhang, Juxiang
    Gu, Meng
    Yang, Yanxi
    Chen, Qi
    Wang, Yuning
    Qian, Kun
    Xu, Bin
    SMALL METHODS, 2025,
  • [37] Managing benign prostatic hyperplasia and prostate cancer - the challenges today
    Marberger, Michael
    JOURNAL OF MENS HEALTH, 2010, 7 (02) : 113 - 124
  • [38] The use of beta-sitosterol for the treatment of prostate cancer and benign prostatic hyperplasia
    Macoska, Jill A.
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2023, 11 (06): : 467 - 480
  • [39] Oxidative Stress and Body Composition in Prostate Cancer and Benign Prostatic Hyperplasia Patients
    Cimino, Sebastiano
    Favilla, Vincenzo
    Russo, Giorgio Ivan
    Galvano, Fabio
    Li Volti, Giovanni
    Barbagallo, Ignazio
    Giofre, Salvatore Vincenzo
    D'Orazio, Nicolantonio
    Di Rosa, Alessandro
    Madonia, Massimo
    Morgia, Giuseppe
    ANTICANCER RESEARCH, 2014, 34 (09) : 5051 - 5056
  • [40] Benign prostatic hyperplasia: racial differences in treatment patterns and prostate cancer prevalence
    Pettaway, Curtis A.
    Lamerato, Lois E.
    Eaddy, Michael T.
    Edwards, Jessie K.
    Hogue, Susan L.
    Crane, Martin M.
    BJU INTERNATIONAL, 2011, 108 (08) : 1302 - 1308
12345